Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

4.5K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.5K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

1.9K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
1.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

2.7K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
2.7K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain barriers as checkpoints in endocrine regulation of body homeostasis.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026
Same author

A CYP11B2 variant (rs7831617) is associated with lower blood pressure and a reduced risk of incident hypertension.

Scientific reports·2026
Same author

Combined leucine supplementation and exercise to counteract sarcopenia in patients with end-stage kidney disease undergoing maintenance hemodialysis: a single-center randomized pilot study.

Kidney research and clinical practice·2026
Same author

Neutrophil-derived itaconate facilitates tiered pulmonary inflammation via Kdm5b-associated epigenetic remodeling in alveolar macrophages.

Cell reports·2026
Same author

Genetic Causes and Ankle Instability in Hypermobile Ehlers-Danlos Syndrome (hEDS): An Integrated Analysis Using Whole-Exome Sequencing and Stress Imaging.

Journal of clinical medicine·2026
Same author

Placental transcriptome profiling and immune signature differences in pregnancies with and without gestational diabetes mellitus: An observational study.

Medicine·2026

Related Experiment Video

Updated: Jun 24, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.3K

Metabolic Reprogramming in Thyroid Cancer.

Sang-Hyeon Ju1, Minchul Song1, Joung Youl Lim1

  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea.

Endocrinology and Metabolism (Seoul, Korea)
|June 10, 2024
PubMed
Summary
This summary is machine-generated.

Targeting thyroid cancer metabolism offers new therapeutic avenues. Combining metabolic inhibitors with other treatments may overcome resistance in aggressive thyroid cancer.

Keywords:
Drug resistance, neoplasmImmunotherapyMetabolic networks and pathwaysThyroid neoplasmsTyrosine kinase inhibitors

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.6K
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.1K

Related Experiment Videos

Last Updated: Jun 24, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.3K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.6K
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.1K

Area of Science:

  • Oncology
  • Endocrinology
  • Cancer Metabolism

Background:

  • Thyroid cancer incidence is rising globally, with aggressive forms posing significant mortality risks.
  • Targeted therapies like RET and BRAF kinase inhibitors show promise but face resistance.
  • Metabolic plasticity presents a challenge in developing effective thyroid cancer treatments.

Purpose of the Study:

  • To review novel therapeutic strategies for thyroid cancer, focusing on metabolic targeting.
  • To discuss promising metabolic inhibitors and their potential in overcoming treatment resistance.
  • To explore the advantages of combined metabolic targeting approaches in advanced thyroid cancer.

Main Methods:

  • Literature review of current research on thyroid cancer therapeutics.
  • Analysis of studies investigating metabolic inhibitors and combinatorial strategies.
  • Discussion of challenges related to metabolic plasticity in cancer treatment.

Main Results:

  • Kinase inhibitors (RET, BRAF) are valuable but limited by resistance mechanisms.
  • Metabolic inhibitors offer a promising strategy to target thyroid cancer cell metabolism.
  • Combinatorial approaches, including dual metabolic inhibition, show potential to overcome resistance.

Conclusions:

  • New therapeutic approaches are crucial for managing aggressive thyroid cancer.
  • Targeting cancer cell metabolism is a key strategy to overcome resistance to targeted therapies.
  • Combined metabolic targeting holds significant potential for advancing thyroid cancer treatment.